Mark Lackner

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Andrea Paul, attorney-in-fact for Mark Lackner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Lackner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 513K $878K $1.71 03 Feb 2025 Direct
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Stock Option (Right to Buy) 125K 03 Feb 2025 Direct

Insider Reports Filed by Mark Lackner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 03 Feb 2025 3 -$24.6K 4 Chief Scientific Officer 05 Feb 2025, 18:32
ZNTL Zentalis Pharmaceuticals, Inc. 02 Jan 2025 1 -$13.8K 4 Chief Scientific Officer 03 Jan 2025, 17:17
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2024 3 -$18.3K 4 Chief Scientific Officer 05 Feb 2024, 19:15
ZNTL Zentalis Pharmaceuticals, Inc. 02 Jan 2024 2 $0 4 Chief Scientific Officer 03 Jan 2024, 20:21
ZNTL Zentalis Pharmaceuticals, Inc. 31 Dec 2023 0 $0 3 Chief Scientific Officer 03 Jan 2024, 20:19